Exploration of Analgesia with Tramadol in the Coxsackievirus B3 Myocarditis Mouse Model
暂无分享,去创建一个
S. Pinkert | K. Klingel | Z. Kaya | A. Heuser | A. Beling | Meike Kespohl | N. Kelm
[1] R. Kloner,et al. Viral myocarditis: 1917–2020: From the Influenza A to the COVID-19 pandemics , 2020, Trends in Cardiovascular Medicine.
[2] S. Van Linthout,et al. Opioid-Induced Immunomodulation: Consequences for the Experimental Coxsackievirus B3-Induced Myocarditis Model , 2020, Biology.
[3] R. Klopfleisch,et al. Development of a New Mouse Model for Coxsackievirus-Induced Myocarditis by Attenuating Coxsackievirus B3 Virulence in the Pancreas. , 2020, Cardiovascular research.
[4] E. Arbustini,et al. Myocardial localization of coronavirus in COVID‐19 cardiogenic shock , 2020, European journal of heart failure.
[5] P. Sacerdote,et al. Do All Opioid Drugs Share the Same Immunomodulatory Properties? A Review From Animal and Human Studies , 2019, Front. Immunol..
[6] R. Klopfleisch,et al. Administration of Tramadol or Buprenorphine via the drinking water for post-operative analgesia in a mouse-osteotomy model , 2019, Scientific Reports.
[7] B. Maisch. Cardio-Immunology of Myocarditis: Focus on Immune Mechanisms and Treatment Options , 2019, Front. Cardiovasc. Med..
[8] P. Lancellotti,et al. [Update on myocarditis]. , 2018, Revue medicale de Liege.
[9] K. Knobeloch,et al. Ubiquitin-Like Protein ISG15 (Interferon-Stimulated Gene of 15 kDa) in Host Defense Against Heart Failure in a Mouse Model of Virus-Induced Cardiomyopathy , 2014, Circulation.
[10] D. Lambert,et al. Opioids and immune modulation: more questions than answers. , 2013, British journal of anaesthesia.
[11] D. Fairweather,et al. Update on coxsackievirus B3 myocarditis , 2012, Current opinion in rheumatology.
[12] B. Schroen,et al. Inflammation in viral myocarditis: friend or foe? , 2012, Trends in molecular medicine.
[13] R. Kloner,et al. Influenza-related viral myocarditis. , 2010, WMJ : official publication of the State Medical Society of Wisconsin.
[14] K. Klingel,et al. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice , 2007, Journal of medical virology.
[15] P. Sacerdote,et al. Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses , 2004, Pain.
[16] H. Sigusch,et al. Coxsackievirus B3-induced myocarditis: differences in the immune response of C57BL/6 and Balb/c mice , 2004, Medical Microbiology and Immunology.
[17] J. Towbin,et al. Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. , 2003, Journal of the American College of Cardiology.
[18] C. Perry,et al. Tramadol , 2000, Drugs.
[19] P. Sacerdote,et al. Effects of tramadol and its enantiomers on Concanavalin-A induced-proliferation and NK activity of mouse splenocytes: involvement of serotonin. , 1999, International journal of immunopharmacology.
[20] P. Sacerdote,et al. Effects of tramadol on experimental inflammation , 1999, Fundamental & clinical pharmacology.
[21] P. Sacerdote,et al. Effects of tramadol on immune responses and nociceptive thresholds in mice , 1997, Pain.
[22] B. McManus,et al. Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets , 1996, Journal of virology.
[23] N. Bowles,et al. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. , 1994, Circulation.
[24] J. Besson,et al. Evidence for a noradrenergic component in the antinociceptive effect of the analgesic agent tramadol in an animal model of clinical pain, the arthritic rat. , 1992, European journal of pharmacology.
[25] K. Leslie,et al. Progressive interstitial collagen deposition in Coxsackievirus B3-induced murine myocarditis. , 1990, The American journal of pathology.
[26] B. Thanopoulos,et al. Cardiac Involvement in Postnatal Rubella , 1989, Acta paediatrica Scandinavica.
[27] G. Dempster,et al. Myocarditis in experimental Coxsackie B-3 infection. , 1959, Canadian journal of microbiology.
[28] M. Souza,et al. Tramadol use in zoologic medicine. , 2011, The veterinary clinics of North America. Exotic animal practice.
[29] S. Grond,et al. Clinical Pharmacology of Tramadol , 2004, Clinical pharmacokinetics.
[30] P. Dayer,et al. [Pharmacology of tramadol]. , 1997, Drugs.
[31] K. Klingel,et al. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.